Effect of berberine chloride on expression of insulin degrading enzyme in rat models with AD
- Author:
- No author available
- Journal Title:
- CHINESE JOURNAL OF NEUROMEDICINE
- Issue:
- 12
- DOI:
- 10.3760/cma.j.issn.1671-8925.2010.12.004
- Key Word:
- 阿尔茨海默病;小檗碱;胰岛素降解酶;Alzheimer's disease;Berberine chloride;Insulin degrading enzyme
Abstract： Objective To explore the effect of berberine chloride on the expression of insulin degrading enzyme (IDE) in the rat models with Alzheimer's disease (AD). Methods Eighteen adult male SD rats, weighting 220-250 g, were randomly divided into normal control group, Aβ1-40 group and Aβ40+berberine chloride group (n=6). The rat models with AD were established by stereotactically injecting condensed Aβ1-40 (5 μg) into the bilateral hippocampus of rats. The rats in the Aβ1-40+berberine chloride group were given berberine chloride (50 mg/kg) by intragastric administration once daily for 14 d. The expressions of IDE were assayed by real time polymerase chain reaction (real-time PCR) and Western blotting. Results The relative quantity of mRNA expression of IDE was (34.2±6.7) in the Aβ1-40+berberine group, which was significantly increased as compared with that in the Aβ1-40 group (45.7±12.8) and normal control group (23.4±11.3, P＜0.05). The relative quantity of protein expression of IDE was (0.61 ±0.05) in the Aββ1-40+berberine group, which was significantly increased as compared with that in the Aβ1-40group (0.46±0.07) and the normal control group (0.23±0.03, P＜0.05). Conclusion The injection of Aβ1-40 (5 μg) in the hippocampus can highly increase the expressions of IDE, thus resulting in the increase effect of Aβ clearance.
- [1]朱飞奇,何国厚,梁志坚,等.小檗碱对阿尔茨海默病大鼠模型小胶质细胞活化的影响[J].2009,(9).
- [2]Wei,J,Pan,HN,Kong,WJ,etc.Berberine reduces insulin resistance through protein kinase C-dependent up-regulation of insulin receptor expression.[J].2009,58(1).
- [3]Mucke L,Roberson ED.100 years and counting: Prospects for defeating Alzheimer's disease[J].2006,314(5800).
- [4]Guo L,Yan Y,Wang C,etc.Cyclophilin D deficiency attenuates mitochondrial and neuronal perturbation and ameliorates learning and memory in Alzheimer's disease.[J].2008,14(10).
- [5]Qin W,Jia J.Down-regulation of insulin-degrading enzyme by presenilin 1 V97L mutant potentially underlies increased levels of amyloid beta 42.[J].2008,27(9).
- [6]Lim GP,Zhao L,Ubeda OJ,etc.Insulin-degrading enzyme as a downstream target of insulin receptor signaling cascade: implications for Alzheimer's disease intervention.[J].2004,24(49).
- [7]Farris W,Mansourian S,Chang Y,etc.Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo.[J].2003,100(7).
- [8]Jung, HA,Min, BS,Yokozawa, T,etc.Anti-Alzheimer and Antioxidant Activities of Coptidis Rhizoma Alkaloids[J].2009,32(8).
- [9]Ishiura S,Saido TC,Yoshikawa A,etc.Berberine alters the processing of Alzheimer's amyloid precursor protein to decrease A beta secretion[J].2007,352(2).
- [10]Farris W,Leissring MA,Wu XN,etc.Alternative translation initiation generates a novel isoform of insulin-degrading enzyme targeted to mitochondria[J].2004,383(Pt.3).
- [11]Du J,Chang J,Guo S.ApoE 4 reduces the expression of Abeta degrading enzyme IDE by activating the NMDA receptor in hippocampal neurons.[J].2009,464(2).
- [12]Kong W,Wei J,Abidi P,etc.Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins.[J].2004,10(12).
- [13]Song ES,Hersh LB.Insulysin: an allosteric enzyme as a target for Alzheimer's disease.[J].2005,25(3).
- [14]Julien JP,Soulet D,Gowing G,etc.Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer's disease.[J].2006,49(4).
- [15]Feiqi, Zhu,Caiyun, Qian.Berberine chloride can ameliorate the spatial memory impairment and increase the expression of interleukin-1beta and inducible nitric oxide synthase in the rat model of Alzheimer's disease.[J].2006,7.